{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:33:26Z","timestamp":1786649606303,"version":"build-2736575974"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Prolonged QTc intervals, psychiatric medications, and associated risks such as sudden cardiac deaths and their cardiovascular safety profile are still being studied globally, given the revolution brought by them in the field of psychiatry.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim:<\/jats:title>\n                    <jats:p>To study the cardiac safety profile of psychotropics in terms of QTc prolongation and establish the safety of psychotropics as a group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>In this study, 121 subjects receiving psychotropic medications were included. ECG of all the patients was performed and followed up to 4 weeks.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The control group showed no difference at any of the three-time intervals, with the mean QTc interval at baseline being 391.3 + 49.70, at one week being 391.3 + 49.70 and at four weeks being 391.3 + 49.70. In contrast, the mean QTc interval for the patients\u2019 group was 352.9 + 64.68 at baseline, 353.3 + 649.70 at one week, and 354.4 + 64.82 after four weeks. The difference was found to be substantial (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001) but negligible (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.078) when the baseline QTc interval was examined for one week. The point that needs to be highlighted here is that significant QTc changes after 4 weeks of starting some psychotropics were noted. However, the number of patients leading to QTc prolongation, i.e. QTc &gt;470 mm\/sec in females and &gt;440 mm\/sec in males, were, in fact, negligible (3 in number).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Based on the prescribed doses of the medications and any Torsade de pointes (TdP) risk factors, those taking psychiatric medications should have a personalized cardiac monitoring routine. Overall, psychotropics have emerged as a safe option for treating psychiatric illnesses. They do impact the QTc interval, but the number of cases presenting with arrhythmia and other life-threatening cardiac side effects are very few that too if monitored, these risks can be avoided.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ipj.ipj_440_24","type":"journal-article","created":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T12:01:44Z","timestamp":1759492904000},"page":"402-407","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["QTc interval in patients on psychotropic medications"],"prefix":"10.4103","volume":"34","author":[{"given":"Iqra Rasheed","family":"Shah","sequence":"first","affiliation":[{"name":"Department of Psychiatry, Institute of Mental Health and Neurosciences (IMHANS) GMC Srinagar, Jammu and Kashmir, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rouf Ahmad","family":"Mir","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Institute of Mental Health and Neurosciences (IMHANS) GMC Srinagar, Jammu and Kashmir, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukrita","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Institute of Mental Health and Neurosciences (IMHANS) GMC Srinagar, Jammu and Kashmir, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fazle Roub","family":"Bhat","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Institute of Mental Health and Neurosciences (IMHANS) GMC Srinagar, Jammu and Kashmir, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arshad","family":"Hussain","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Institute of Mental Health and Neurosciences (IMHANS) GMC Srinagar, Jammu and Kashmir, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harsh Kumar","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Institute of Mental Health and Neurosciences (IMHANS) GMC Srinagar, Jammu and Kashmir, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,10,1]]},"reference":[{"key":"R1-20260420","article-title":"Kaplan & Sadock's synopsis of psychiatry: behavioral sciences\/clinical psychiatry","author":"Benjamin","year":"2007"},{"key":"R2-20260420","doi-asserted-by":"crossref","first-page":"110138","DOI":"10.1016\/j.jpsychores.2020.110138","article-title":"QTc monitoring in adults with medical and psychiatric comorbidities: Expert consensus from the Association of Medicine and Psychiatry","volume":"135","author":"Xiong","year":"2020","journal-title":"J Psychosom Res"},{"key":"R3-20260420","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1176\/appi.ajp.2019.1760501","article-title":"QTc Prolongation and psychotropic medications","volume":"177","author":"Funk","year":"2020","journal-title":"Am J Psychiatry"},{"key":"R4-20260420","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s12888-020-02687-w","article-title":"Prevalence of QTc interval prolongation and its associated risk factors among psychiatric patients: A prospective observational study","volume":"20","author":"Ali","year":"2020","journal-title":"BMC Psychiatry"},{"key":"R5-20260420","doi-asserted-by":"crossref","first-page":"2045125319891386","DOI":"10.1177\/2045125319891386","article-title":"Prevalence of ECG abnormalities and risk factors for QTc interval prolongation in hospitalized psychiatric patients","volume":"9","author":"Ansermot","year":"2019","journal-title":"Ther Adv Psychopharmacol"},{"key":"R6-20260420","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/JCP.0b013e318191c6a8","article-title":"Psychotropic drugs associated with corrected QT interval prolongation","volume":"29","author":"van Noord","year":"2009","journal-title":"J Clin Psychopharmacol"},{"key":"R7-20260420","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/archinte.164.9.943","article-title":"Prolonged QTc interval and risks of total and cardiovascular mortality and sudden death in the general population: A review and qualitative overview of the prospective cohort studies","volume":"164","author":"Montanez","year":"2004","journal-title":"Arch Intern Med"},{"key":"R8-20260420","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1176\/appi.ajp.158.11.1774","article-title":"Antipsychotic drugs: Prolonged QTc interval, Torsade de pointes, and sudden death","volume":"158","author":"Glassman","year":"2001","journal-title":"Am J Psychiatry"},{"key":"R9-20260420","first-page":"755","article-title":"Non-adherence with pharmacotherapy among patients attending psychiatry OPD: A study from Kashmir","volume":"3","author":"Dar","year":"2016","journal-title":"Int J Contemp Med Res"},{"key":"R10-20260420","first-page":"PY20","article-title":"Prevalence and distribution of psychiatric disorders among patients visiting psychiatry OPD in a tertiary care center in Mangalore","volume":"7","author":"Deepthi","year":"2019","journal-title":"Asian J Med Res"},{"key":"R11-20260420","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S0140-6736(00)02035-3","article-title":"QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients","volume":"355","author":"Reilly","year":"2000","journal-title":"Lancet"},{"key":"R12-20260420","first-page":"11","article-title":"Use of tricyclic antidepressants as analgesic adjuvants results in nonhazardous prolongation of the QTc interval","volume":"60","author":"Funai","year":"2014","journal-title":"Osaka City Med J"},{"key":"R13-20260420","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/j.ijcard.2007.08.006","article-title":"Citalopram induced Torsade de pointes, a rare life-threatening side effect","volume":"131","author":"Kanjanauthai","year":"2008","journal-title":"Int J Cardiol"},{"key":"R14-20260420","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2174\/157488610789869265","article-title":"QT alterations in psychopharmacology: Proven candidates and suspects","volume":"5","author":"Alvarez","year":"2010","journal-title":"Curr Drug Saf"},{"key":"R15-20260420","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0002-9149(97)00888-6","article-title":"Torsades de Pointes associated with intravenous haloperidol in critically ill patients","volume":"81","author":"Sharma","year":"1998","journal-title":"Am J Cardiol"},{"key":"R16-20260420","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.2165\/00003495-200262110-00006","article-title":"Antipsychotic-related QTc prolongation, Torsade de pointes, and sudden death","volume":"62","author":"Haddad","year":"2002","journal-title":"Drugs"}],"container-title":["Industrial Psychiatry Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ipj.ipj_440_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:55:58Z","timestamp":1786647358000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ipj.ipj_440_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/ipj.ipj_440_24","relation":{},"ISSN":["0972-6748","0976-2795"],"issn-type":[{"value":"0972-6748","type":"print"},{"value":"0976-2795","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"2024-10-26","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-19","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}